Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
EC/CAS
215-185-5
Name of the chemical
Potassium or sodium hydroxide (20)
Concentration
N/A
General Information
Revision date
2021-08-13
Product name
DECATARTRE LIQUIDE
CAS No.
1310-73-2
supplier name
LAFFORT FRANCE SAS
Emergency telephone
Comment
Icons in SDS
Company Information
company name
LAFFORT FRANCE SAS
e-mail address of the competent person responsible for the Safety Data Sheet
info@laffort.com, laffortitalia@laffort.com, laffortusa@laffort.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H314, H318
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
CLP CLASSIFICATION
Skin corrosion/irritation, Category 1 H314 Serious eye damage/eye irritation, Category 1 H318 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]
Hazard pictograms
GHS05
Signal word
Danger
Contains
Sodium hydroxide
Hazard statements
H314 - Causes severe skin burns and eye damage. H318 - Causes serious eye damage.
Precautionary statements
P280 - Wear protective gloves, eye protection, face protection. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water or shower. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER, a doctor.
Other hazards which do not result in classification
Do not mix with acids. Do not mix with : Ammonia. May develop chlorine if mixed with acidic solutions. The product does not meet the PBT and vPvB classification criteria
Further information
The product does not meet the PBT and vPvB classification criteria. The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
